Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Debt (2016 - 2025)

Historic Total Debt for Sanara MedTech (SMTI) over the last 12 years, with Q3 2025 value amounting to $45.1 million.

  • Sanara MedTech's Total Debt rose 4991.59% to $45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.1 million, marking a year-over-year increase of 4991.59%. This contributed to the annual value of $30.7 million for FY2024, which is 21659.72% up from last year.
  • Per Sanara MedTech's latest filing, its Total Debt stood at $45.1 million for Q3 2025, which was up 4991.59% from $44.2 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Total Debt ranged from a high of $45.1 million in Q3 2025 and a low of $9.7 million during Q3 2023
  • In the last 3 years, Sanara MedTech's Total Debt had a median value of $30.1 million in 2024 and averaged $26.6 million.
  • Over the last 5 years, Sanara MedTech's Total Debt had its largest YoY gain of 26881.59% in 2025, and its largest YoY loss of 4991.59% in 2025.
  • Quarter analysis of 3 years shows Sanara MedTech's Total Debt stood at $9.7 million in 2023, then surged by 216.6% to $30.7 million in 2024, then skyrocketed by 46.92% to $45.1 million in 2025.
  • Its Total Debt stands at $45.1 million for Q3 2025, versus $44.2 million for Q2 2025 and $43.4 million for Q1 2025.